Invoke Capital

Luminance develops an AI-powered platform for contract generation, negotiation, and post-execution analysis. Its proprietary legal language model is designed to process and understand legal documents with a focus on accuracy and compliance. The platform combines generative and analytical AI to assist businesses in managing contract-related workflows. Luminance is used by organizations across various industries to streamline legal document review and decision-making.

Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countries to prevent fraud and financial crime. ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.

Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countries to prevent fraud and financial crime. ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.

SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.

Luminance develops an AI-powered platform for contract generation, negotiation, and post-execution analysis. Its proprietary legal language model is designed to process and understand legal documents with a focus on accuracy and compliance. The platform combines generative and analytical AI to assist businesses in managing contract-related workflows. Luminance is used by organizations across various industries to streamline legal document review and decision-making.

Darktrace's self-learning AI is modeled on the human immune system and used by over 3,500 organizations to protect against threats to the cloud, email, IoT, networks, and industrial systems. This includes insider threat, industrial espionage, IoT compromises, zero-day malware, data loss, supply chain risk, and long-term infrastructure vulnerabilities. Darktrace has over 1,200 employees, 44 offices and headquarters in San Francisco and Cambridge, UK. Every 3 seconds, Darktrace AI fights back against a cyber-threat, preventing it from causing damage.

Neurence was founded by a group of world-class mathematicians and software engineers in Cambridge, England. Representing one of Europe's premier technical groups, the team at Neurence has built a highly intelligent, cloud-based central repository of information: Neurence acts like a "brain", with an ability to actually see, hear and understand the world around it. By using new mathematical and computational algorithms which power our cloud architecture, devices can be connected into and powered by Neurence, 'outsourcing' the processing of information from on-board the device into Neurence's intelligent cloud. By communicating all sensory data to Neurence, devices can access Neurence's knowledge to react to situations in the most effective and efficient way yet. This cloud-based machine learning means that each device does not need on-board processing power, allowing devices to be lighter, faster and less expensive to manufacture.Neurence is hosted in a shared cloud storage architecture, meaning devices and applications can consult the brain when they come across a new situation. As Neurence learns from the experience of all connected devices, Neurence will automatically instruct the device on what to do based on the optimal outcome of other devices' history.

SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.

Darktrace's self-learning AI is modeled on the human immune system and used by over 3,500 organizations to protect against threats to the cloud, email, IoT, networks, and industrial systems. This includes insider threat, industrial espionage, IoT compromises, zero-day malware, data loss, supply chain risk, and long-term infrastructure vulnerabilities. Darktrace has over 1,200 employees, 44 offices and headquarters in San Francisco and Cambridge, UK. Every 3 seconds, Darktrace AI fights back against a cyber-threat, preventing it from causing damage.